Translational adaptation in breast cancer metastasis and emerging therapeutic opportunities

S Chen, A Navickas, H Goodarzi - Trends in Pharmacological Sciences, 2024 - cell.com
Breast cancer's tendency to metastasize poses a critical barrier to effective treatment,
making it a leading cause of mortality among women worldwide. A growing body of …

Genetic reduction of mammalian target of rapamycin ameliorates Alzheimer's disease-like cognitive and pathological deficits by restoring hippocampal gene …

A Caccamo, V De Pinto, A Messina, C Branca… - Journal of …, 2014 - jneurosci.org
Elevated mammalian target of rapamycin (mTOR) signaling has been found in Alzheimer's
disease (AD) patients and is linked to diabetes and aging, two known risk factors for AD …

New targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancers

AHN Kamdje, PFS Etet, L Vecchio… - World Journal of …, 2014 - pmc.ncbi.nlm.nih.gov
Breast cancer is the most frequent female malignancy worldwide. Current strategies in
breast cancer therapy, including classical chemotherapy, hormone therapy, and targeted …

Repurposing of Guanabenz acetate by encapsulation into long-circulating nanopolymersomes for treatment of triple-negative breast cancer

YA Haggag, M Yasser, MM Tambuwala… - International Journal of …, 2021 - Elsevier
Poor patient response and limited treatment modalities are the major challenges against
combating triple-negative breast cancer (TNBC). The high related mortality urges for novel …

eIF4A/PDCD4 pathway, a factor for doxorubicin chemoresistance in a triple-negative breast cancer cell model

A González-Ortiz, A Pulido-Capiz… - Cells, 2022 - mdpi.com
Cells employ several adaptive mechanisms under conditions of accelerated cell division,
such as the unfolded protein response (UPR). The UPR is composed of a tripartite signaling …

mTORC2 balances AKT activation and eIF2α serine 51 phosphorylation to promote survival under stress

C Tenkerian, J Krishnamoorthy, Z Mounir… - Molecular Cancer …, 2015 - aacrjournals.org
The mTOR nucleates two complexes, namely mTOR complex 1 and 2 (mTORC1 and
mTORC2), which are implicated in cell growth, survival, metabolism, and cancer …

[HTML][HTML] Activation of endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance of human small cell lung cancer cells by …

XS Yu, J Du, YJ Fan, FJ Liu, LL Cao, N Liang… - …, 2016 - pmc.ncbi.nlm.nih.gov
Objective This study aims to investigate the effects of endoplasmic reticulum stress (ERS) on
autophagy, apoptosis and chemoresistance of human small cell lung cancer (SCLC) cells …

Interconnection of estrogen/testosterone metabolism and mevalonate pathway in breast and prostate cancers

P Mokarram, J Alizadeh, V Razban… - Current molecular …, 2017 - ingentaconnect.com
The metabolic steroid hormones, 17β stradiol (E2) and testosterone play key roles in several
functions including carbohydrate, lipid and protein metabolism, cellular signaling, cell …

Overcoming resistance of cancer cells to PARP-1 inhibitors with three different drug combinations

M Yalon, L Tuval-Kochen, D Castel, I Moshe, I Mazal… - PloS one, 2016 - journals.plos.org
Inhibitors of poly [ADP-ribose] polymerase 1 (PARPis) show promise for treatment of cancers
which lack capacity for homologous recombination repair (HRR). However, new therapeutic …

Pediatric glioblastoma cells are sensitive to drugs that inhibit eIF2α dephosphorylation and its phosphomimetic S51D variant

K Eytan, Z Versano, R Oren, J Jacob-Hirsch… - Frontiers in …, 2022 - frontiersin.org
We found that pediatric glioblastoma (PED-GBM) cell lines from diffuse intrinsic pontine
glioma (DIPG) carrying the H3K27M mutation or from diffuse hemispheric glioma expressing …